. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2022 Jan 23;89(2):231–242. doi: 10.1007/s00280-021-04388-x
Under no circumstances may this AM be shared or distributed under a Creative Commons or other form of open access license, nor may it be reformatted or enhanced, whether by the Author or third parties. See here for Springer Nature’s terms of use for AM versions of subscription articles: https://www.springernature.com/gp/open-research/policies/accepted-manuscript-terms